HENLIUS Announces Board Leadership Change as Xingli Wang Named Chairman of Fourth Board

HENLIUS (ASX: 02696) has issued an announcement regarding significant changes to its board composition.

Due to personal development reasons, Mr. Wenjie Zhang has tendered his resignation as a non-executive director of the company and chairman of the board, member and chairman of the nomination committee, member and chairman of the strategy committee, as well as member of the environmental, social and governance committee, effective from September 30, 2026.

Mr. Wenjie Zhang has confirmed that he has no disagreement with the board and that there are no other matters relating to his resignation that need to be brought to the attention of the company's shareholders.

Due to personal development reasons, Mr. Yihao Zhang has tendered his resignation as an independent non-executive director of the company and member of the nomination committee, effective from September 30, 2026.

Mr. Yihao Zhang has confirmed that he has no disagreement with the board and that there are no other matters relating to his resignation that need to be brought to the attention of shareholders.

The board is pleased to announce that Mr. Huang Zhi (Mr. Huang) and Dr. Chen Huajun (Dr. Chen) have respectively been nominated to serve as non-executive director and independent non-executive director of the fourth board of directors, subject to approval by shareholders at the shareholders' meeting.

Dr. Xingli Wang (Dr. Wang) has been appointed as chairman of the fourth board of directors, member and chairman of the nomination committee, chairman of the strategy committee, as well as member of the environmental, social and governance committee, effective from September 30, 2026.